You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 10, 2018

Vietnam: Does Subsequent Cancellation of a Patent Justify a Retrial?

Managing Intellectual Property

In the Vietnamese judicial system, there are two avenues for reviewing a court’s final judgment. Under the current procedural legislation, if such judgment can be shown to be based on a serious error of law, it can go through the process of cassation, where the judgment will be reviewed and possibly annulled due to the material error in the procedures. If, on the other hand, new evidence or facts are discovered that could have affected the outcome of the case, the case can be retried.

Recently, the Supreme People’s Court applied the procedure of retrial to a 2011 patent infringement case following the cancellation of the patent in question, a decision that could set an interesting precedent for future intellectual property disputes.

In this case, which involved a Vietnamese company’s utility solution patent for a shaped aluminum bar, the People’s Court of Ho Chi Minh City had issued a first-instance judgment in favor of the plaintiff, requesting the defendant to make a public apology and pay damages for its infringement of the patent. The appellate court then denied the defendant’s appeal in a June 2012 decision and upheld the first-instance judgment.

An appellate verdict is considered an effective final judgment and, in principle, closes the process of hearing a case. However, in this case, an unexpected situation arose when the utility solution patent was canceled by the National Office of Intellectual Property (NOIP) seven months later, in January 2013. After the cancellation, the defendant filed a petition requesting the court to review the case under the procedure of retrial.

The Supreme People’s Court ruled, in a 2016 decision that was only recently made public, that the case should be retried. The decision did not provide any analysis or guidance, but it appears that the Supreme People’s Court automatically considered the cancellation of the patent as a “new fact” and thus canceled the entire first-instance judgment as well as the appellate verdict, handing the case back to the first-instance court for retrial.

This decision was unexpected, and raises questions about the proper interpretation of the law. The key issue is whether the subsequent cancellation of the patent in question, which had been fully effective at the time of the first-instance and appellate trials, should be regarded as a “new fact” which the court could rely on to approve a retrial.

Pursuant to Article 304 of the 2004 Civil Procedure Code (which was still valid at the time of the first-instance and appellate trials, as well as the time the retrial was ordered), the grounds for retrying a case must be a newly discovered fact which the court and the involved parties were unaware of when the court issued the judgment or ruling. The term “discover” here would seem to indicate that this fact must have inherently existed at the time of the original trial, and not have occurred subsequently. In this case, however, the parties were not aware of such new fact because the fact did not exist until after the judgment took effect. Nevertheless, the Supreme People’s Court held that the patent cancellation was valid grounds for a retrial.

While the Supreme People’s Court’s decision in this case has not yet been widely discussed, it could end up having a major impact on the settlement of IP cases if it serves as a precedent. Vietnam does not have a system of specialized IP courts; thus, in principle, despite many judges lacking deep legal and technical knowledge in IP, any court can be given jurisdiction over an IP case, whether such case is simple or extremely complicated. It is likely that the courts will give more weight to NOIP invalidation proceedings when settling IP disputes, to avoid potential reversal of the final judgments. Some courts may even stay the infringement proceedings pending the final outcomes of the nullity process before the NOIP, as happened recently in a case before the Binh Duong provincial court involving the infringement of a pharmaceutical patent.

The NOIP, unfortunately, is not known for its timeliness in settling patent cancellations. The process may take years, and in some cases there might never be a final decision. If the courts insist on waiting for cancellation decisions before issuing judgments in IP dispute cases, the plaintiffs may face a very long wait indeed. Further clarification is needed on this matter, and invalidation proceedings at the NOIP should be fast-tracked, to ensure that IP owners’ rights are protected.

RELATED INSIGHTS​ 

July 25, 2025
Over the first half of 2025, the government of Vietnam has implemented a comprehensive suite of legislative reforms that significantly impact the country’s intellectual property (IP) framework. These amendments, most of which took effect on 1 July 2025, span the criminal, civil, administrative, and judicial sectors, and are part of a broader initiative to modernize Vietnam’s legal infrastructure, strengthen enforcement mechanisms, and harmonize domestic regulations with international standards. A summary of the key legislative changes and their potential implications for IP protection and enforcement across Vietnam is provided below. Criminal Code: Stricter penalties Under the 2025 amendments to Vietnam’s Criminal Code, penalties for offenses involving the manufacturing and trading of counterfeit goods have been significantly escalated. Individuals convicted of such violations now face fines ranging from VND 200 million to VND 2 billion (approximately USD 7,700 to USD 77,000; up from VND 100 million to VND 1 billion). For corporate entities, the penalties are even more severe, with fines ranging from VND 2 billion to VND 40 billion (roughly USD 77,000 to USD 1.54 million; up from VND 1 billion to VND 20 billion). These heightened penalties reflect the government’s intensified efforts to deter counterfeit-related crimes and protect consumer rights. Law on Handling Administrative Violations: Extended statute of limitations and application of electronic procedure The statute of limitations for addressing administrative violations in the IP sector is still two years. However, in cases where such violations are referred by procedural authorities, this period is extended by one year. The time taken by these authorities to process the case is now included within the overall limitation period. In addition, the Law on Handling Administrative Violations facilitates the use of electronic procedures, provided that the necessary infrastructure, technical systems, and information conditions are in place. Specifically, enforcement authorities are now permitted
July 21, 2025
Distinctiveness is a fundamental requirement for a trademark’s registration and protection under Thai law. The Thai courts typically assess distinctiveness based on a mark’s inherent characteristics rather than its use, as proving acquired distinctiveness through use requires substantial evidence, including the duration of use, extent of distribution and promotional efforts. However, the Intellectual Property and International Trade Court (IP & IT Court) has recently ruled that the figurative mark WEPLAY had acquired distinctiveness through use – an uncommon ruling under Thai trademark law. Subsequently, the Court of Appeal for Specialised Cases affirmed the mark’s inherent distinctiveness based on a holistic assessment of its components. This article discusses the criteria for proving both inherent and acquired distinctiveness, offering examples from both courts to provide valuable insights into case preparation and understanding of how the courts assess distinctiveness. Background In 2017 the plaintiff filed a trademark application for the mark depicted below for goods in Class 28, including toy building blocks: The registrar rejected the application on the grounds of non-distinctiveness under Section 7 of the Trademark Act. The plaintiff appealed to the Board of Trademarks, which considered that, when the term ‘weplay’ is used for goods in Class 28, it is descriptive of the nature of the goods applied for as “playthings”. Therefore, ‘weplay’ was deemed nondistinctive under Section 7, Paragraph 2(2) of the Trademark Act. IP & IT Court decision In 2024 the IP & IT Court ruled that the term ‘weplay’ is not a coined or invented word; instead, it is a combination of ‘we’ and ‘play’, conveying the meaning of ‘we play’. When the term is used for goods in Class 28, it describes the nature of the goods as “playthings”. Consequently, the mark was deemed non-distinctive. However, the court considered the evidence presented by the plaintiff,
July 14, 2025
Life sciences specialists from Tilleke & Gibbins have updated the firm’s guide to pharmaceutical data exclusivity regulations and practices in Southeast Asia. This guide contains quick-reference information on the availability of data exclusivity protections and limitations in Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, and Vietnam. Developing and launching a new drug on a commercial scale requires an enormous amount of time and investment in research and development (R&D), including pre-clinical testing and clinical trials. When considering the aggregate amount of drug development costs, it is important to recognize that this includes not only the investment in developing new drugs that get approved by a government food and drug regulator and are successfully brought to market, but also the R&D expenditures on a large number of potential pharmaceutical compounds and products that never actually make it to market. In particular, considerable investment is required in order to conduct and produce clinical trial data—to prove safety, efficacy and effectiveness of a new drug—that would warrant marketing approval by the regulatory authority. Such data is proprietary in nature and highly valuable for a research-based pharmaceutical company that develops an original drug. On the other hand, patent law typically confers generic drug manufacturers with the ability to engage in various preparatory activities with a view to obtaining marketing approval for a generic product before the patent for the original drug expires (commonly known as a “Bolar provision”). Since a generic drug maker may submit an application for marketing approval of a generic product before the relevant patent expires, the extent to which the drug originator’s data submitted to the regulatory authority is protected—or in other words, the extent to which the generic company may rely on the drug originator’s previously filed data, which underpins the safety and efficacy of the drug, to support
June 30, 2025
Vietnam is making notable strides in decentralization, aiming to grant greater autonomy to local government entities to streamline administrative procedures. As part of this effort, the government issued Decree No. 133/2025/ND-CP on decentralization of state management of the Ministry of Science and Technology dated June 12, 2025 (Decree 133). Effective from July 1, 2025, Decree 133 decentralizes and delegates numerous state management functions—including in intellectual property (IP) and technology transfer—to provincial-level People’s Committees (PCs). This reform signals a profound shift in how IP rights are administered and enforced across Vietnam. While this offers new opportunities for IP owners, agents, and innovators, it also introduces additional operational complexities. Impact on IP and Technology Transfer Decree 133 significantly reallocates responsibilities in IP and technology transfer, primarily to provincial-level PCs. Provincial PCs and other provincial authorities are now empowered to handle a wide range of tasks, including but not limited to the following: Issuance of duplicates and reissuance of certificates of registration. Registration of license agreements for the transfer of usage rights for industrial property objects (e.g., trademarks, patents) and recording amendments, extensions, or early terminations of such agreements. Enforcing decisions on compulsory licensing of patent use rights. Evaluation and approval of technology transfer contracts—a key step in facilitating localized technological advancements. Permitting the establishment of foreign-invested scientific organizations and their branches, to encourage foreign direct investment in local R&D and technology development. Approval of provincial-level R&D tasks, aligning with local socio-economic development priorities. Legal Implications The decentralization and delegation brought forth by Decree 133 carry several significant legal implications: Echoing Decree 133, the Intellectual Property Office of Vietnam issued Notification No. 2351/TB-SHTT on June 26, 2025, announcing the cessation of 19 administrative procedures at the national level. Specifically, from July 1, 2025, the IP Office will no longer accept requests related